Snapshot
- A 50-year-old healthcare worker presents to the emergency room after a month-long trip to India. He reports having fevers, abdominal pain, and a 5-lb weight loss over the past week. He recalls being bit by multiple types of bugs during his summer month in India. His past medical history includes gonorrheal urethritis. His social history includes having several different male sexual partners over the past year often without protection. On physical exam, there is hepatosplenomegaly. He is treated for a presumed parasitic infection, given his clinical risk factors, and tested for HIV. (Visceral leishmaniasis)
Introduction
- Protozoa
- single-celled eukaryotes, often parasitic, that feed on organic tissues
Trypanosoma cruzi
- Introduction
- Presentation
- Imaging
- Studies
- Treatment
Leishmania donovani
- Introduction
- clinical syndrome
- visceral leishmaniasis (also known as kala-azar or black fever)
- cutaneous leishmaniasis
- transmission
- via sandfly bites
- demographics
- younger children
- mostly found in India, Bangladesh, Sudan, Ethiopia, and Brazil
- risk factors
- HIV/AIDS
- prognosis
- visceral leishmaniasis is fatal without treatment
- clinical syndrome
- Presentation
- Studies
- Treatment
- amphotericin B or sodium stibogluconate
- first-line
- miltefosine
- second-line
- amphotericin B or sodium stibogluconate
- Complications
- post-kala-azar dermal leishmaniasis
- chronic skin rash with onset months to years after treatment
- erythematous or hypopigmented polymorphic lesions throughout the body
- post-kala-azar dermal leishmaniasis